The development of multimodal AI for clincial decision making in immunotherapy
NCI Systems Biology shared a post on X:
“On Aug. 29 at 2:30 pm ET, Anant Madabhushi will discuss the development of multimodal AI for clinical decision-making related to immunotherapy during an National Cancer Institute (NCI) and Society for Immunotherapy of Cancer (SITC) computational ImmunoOncology webinar.”
Source: NCI Systems Biology/X
Dr. Anant Madabhushi is the Robert W. Woodruff Professor in the Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Tech. He is the founding director of the Emory Empathetic AI for Health Institute and co-founder of Picture Health, Ibris Inc, and Elucid Bioimaging. His expertise includes artificial intelligence, medical imaging, cancer detection and diagnosis, MRI, digital pathology, and machine learning.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023